MarketPeel
Insider Trading Intelligence
Pricing
…
SK

Stephen W. Kaldor

CRNX
DIRECTOR · CRINETICS PHARMACEUTICALS, INC. · CIK 0001507502
FILING MIX · LIFETIME100%/0%
BUYS
1
SELLS
0
TOTAL VALUE
$0
COMPANIES
1
ACTIVE SINCE
Jun 2020
HOLDINGS NOW
12,500
AVG SELL PX
—
TRADE KIND
SHOWING 1 / 1
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for Stephen W. Kaldor. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
Not enough transaction history to chart holdings.
Trading cadence · quarterly flow
BUY ● SELL ●
2020
FLOW · 1 buys / 0 sellsCOVERAGE · 1 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILED
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
12,500——12,500Jun 19, 2020Jun 22, 2020 ↗
Other insiders · CRNX
Loading peer insiders…
About this filer
CIK 0001507502
ROLE
Director
PRIMARY
CRNX
COMPANIES
1
ACTIVE SINCE
Jun 2020
MARKETPEEL · /INSIDER/0001507502DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback